IMMUCELL CORP /DE/ - FORM 10-Q - EX-32 - CERTIFICATION PURSUANT TO SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 - August 16, 2010

Attached files

file filename
10-Q - FORM 10-Q - IMMUCELL CORP /DE/d10q.htm
EX-31 - CERTIFICATIONS REQUIRED BY RULE 13A-14(A) - IMMUCELL CORP /DE/dex31.htm
EX-10.3 - COMMERCIAL PROMISSORY NOTE FOR $600,000 - IMMUCELL CORP /DE/dex103.htm
EX-10.5 - LOAN AGREEMENT BETWEEN THE COMPANY AND TD BANK, N.A. - IMMUCELL CORP /DE/dex105.htm
EX-10.2 - COMMERCIAL PROMISSORY NOTE FOR $1,000,000 - IMMUCELL CORP /DE/dex102.htm
EX-10.1 - DEVELOPMENT AND MANUFACTURING AGREEMENT - IMMUCELL CORP /DE/dex101.htm
EX-10.4 - LINE OF CREDIT AGREEMENT AND PROMISSORY NOTE FOR UP TO $500,000 - IMMUCELL CORP /DE/dex104.htm

EXHIBIT 32

ImmuCell Corporation

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of ImmuCell Corporation (the “Company”) for the quarter ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael F. Brigham, President, Chief Executive Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Michael F. Brigham

Michael F. Brigham

President, Chief Executive Officer

and Principal Financial Officer

August 16, 2010

 

 

 

A signed original of this written statement required by Section 906 has been provided to ImmuCell Corporation and will be retained by ImmuCell Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

IMMUCELL CORP /DE/ Reports